Allergy and asthma.

Initiation and regulation of allergic inflammation is influenced by many factors, including cell type, membrane receptors, and mediators generated. Furthermore, the altered response of targeted tissues (ie, airway smooth muscle) becomes important to the eventual expression of asthma. Finally, the genetic regulation and association of genetic polymorphisms has enhanced our understanding of host susceptibility. In this review key findings published in 2004 issues of the Journal of Allergy and Clinical Immunology are highlighted to demonstrate recent advances in these areas.

[1]  A. Togias,et al.  Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. , 1997, Journal of immunology.

[2]  A. Togias,et al.  Systemic effects of allergen exposure on blood basophil IL-13 secretion and FcεRIβ , 2004 .

[3]  N. Hunt,et al.  Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? , 2004, The Journal of allergy and clinical immunology.

[4]  Maree H. Poniris,et al.  Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. , 2004, The Journal of allergy and clinical immunology.

[5]  J. Oliver,et al.  Syk deficiency in nonreleaser basophils. , 1999, The Journal of allergy and clinical immunology.

[6]  D. Gilliland,et al.  Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. , 2003, Blood.

[7]  A. Togias,et al.  Omalizumab-induced reductions in mast cell FcεRI expression and function , 2004 .

[8]  Janette K Burgess,et al.  Increased sensitivity of asthmatic airway smooth muscle cells to prostaglandin E2 might be mediated by increased numbers of E-prostanoid receptors. , 2004, The Journal of allergy and clinical immunology.

[9]  E. Silverman,et al.  ADAM33 polymorphisms and phenotype associations in childhood asthma. , 2004, The Journal of allergy and clinical immunology.

[10]  Steuart Rorke,et al.  Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness , 2002, Nature.

[11]  T. Casale,et al.  Omalizumab treatment downregulates dendritic cell FcεRI expression , 2003 .

[12]  W. Busse,et al.  Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. , 2004, The Journal of allergy and clinical immunology.

[13]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[14]  G. Jin,et al.  Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. , 2004, The Journal of allergy and clinical immunology.

[15]  J. Ring,et al.  Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. , 2003, The New England journal of medicine.

[16]  E. Lenkiewicz,et al.  Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.

[17]  T. Casale,et al.  Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils , 2004 .

[18]  B. O'connor,et al.  Expression of prostaglandin E(2) receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge. , 2004, The Journal of allergy and clinical immunology.

[19]  P. Söderkvist,et al.  A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. , 2004, The Journal of allergy and clinical immunology.

[20]  P. O'Byrne,et al.  Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. , 2004, The Journal of allergy and clinical immunology.

[21]  T. Haverty,et al.  Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700. , 2004, The Journal of allergy and clinical immunology.

[22]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[23]  M. Buckley,et al.  The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation. , 2003, The Journal of allergy and clinical immunology.

[24]  S. Dreskin,et al.  The effect of a novel inhibitor of mast cell activation on mediators, symptoms and nasal patency in allergic rhinitis , 2004 .

[25]  Q. Hamid,et al.  CD4+ T cells migrate from airway to bone marrow after antigen inhalation in rats. , 2004, The Journal of allergy and clinical immunology.

[26]  E. Gelfand,et al.  Migration and accumulation of eosinophils toward regional lymph nodes after airway allergen challenge. , 2004, The Journal of allergy and clinical immunology.

[27]  Q. Hamid,et al.  CD8+ αβ T cells can mediate late airway responses and airway eosinophilia in rats , 2004 .

[28]  J. Lötvall,et al.  Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. , 2004, The Journal of allergy and clinical immunology.

[29]  L. Schwartz,et al.  Expression of α-tryptase and β-tryptase by human basophils , 2004 .

[30]  C. Delacourt,et al.  Both inflammation and remodeling influence nitric oxide output in children with refractory asthma. , 2004, The Journal of allergy and clinical immunology.

[31]  A. Saxon,et al.  Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein , 2004 .

[32]  D. Nowak,et al.  Toll-like receptor 2 as a major gene for asthma in children of European farmers. , 2004, The Journal of allergy and clinical immunology.

[33]  J. Boyce,et al.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. , 2004, The Journal of allergy and clinical immunology.

[34]  D. MacGlashan,et al.  Loss of syk kinase during IgE-mediated stimulation of human basophils. , 2004, The Journal of allergy and clinical immunology.

[35]  B. Lie,et al.  CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigm. , 2004, The Journal of allergy and clinical immunology.

[36]  K. Rabe,et al.  TGF-β differentially regulates TH2 cytokine-induced eotaxin and eotaxin-3 release by human airway smooth muscle cells , 2004 .

[37]  S. Permutt,et al.  Role of nasal nitric oxide in the resolution of experimental rhinovirus infection. , 2004, The Journal of allergy and clinical immunology.